Cite

HARVARD Citation

    Papadopoulos, K. et al. (n.d.). 1140PDPhase I study of KN035, a novel fusion Anti-PD-L1 antibody administered subcutaneously in patients with advanced solid tumors in the USA. Annals of oncology. p. . [Online]. 
  
Back to record